Back

Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de dovo coronary lesions: A five-year analysis from the ORPKI Registry

30 August 2026 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Drug-coated balloon or drug-eluting stent: tailoring de novo interventions Devices ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Tomasz Rakowski

Jagiellonian University, Krakow (Poland)

3 More presentations in this session

Presentation thumbnail
Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry
Doctor I. Kachrimanidis (Athens, GR)
Abstract
Presentation thumbnail
Impact of routine angiographic follow-up on long-term clinical outcomes in patients with multivessel disease underwent successful percutaneous coronary intervention
Mrs Y. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation in patients with proximal LAD disease undergoing drug-coated balloon angioplasty: insights from the REC-CAGEFREE II trial
Professor C. Gao (Hefei, CN)
Abstract

Access the full session

Session thumbnail
Drug-coated balloon or drug-eluting stent: tailoring de novo interventions

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Lesion preparation as an independent determinant of outcomes after drug-coated balloon angioplasty: evidence from clinical, angiographic and functional assessment in observational cohort
19 February 2026
thumbnail
Congress Presentation
Temporal trends in long coronary chronic total occlusion interventions: the Japanese CTO-PCI expert registry
1 September 2025
thumbnail
Congress Presentation
Temporal trends in the use of drug-coated balloons
31 August 2024
thumbnail
Congress Presentation
Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources